Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade - Concepedia

Concepedia

Publication | Open Access

Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade

DOI Full Paper Access

10

Citations

45

References

2024

Year

Nicola Principe, Amber‐Lee Phung, Kofi L P Stevens, Omar Elaskalani, Ben Wylie, Caitlin M. Tilsed, Fezaan Sheikh, M. Lizeth Orozco Morales, Joel Kidman, Elly Marcq,

Journal for ImmunoTherapy of Cancer

Abstract

Changes in immune checkpoint expression on TILs during chemotherapy administration informs selection of ICB therapies to combine with.

References

	Year	Citations

Page 1